Publications

Publications by Kjersti Flatmark

34 publications found

Publications in press

1. Brusegard K, Stavnes HT, Nymoen DA, Flatmark K, Trope CG, Davidson B
   Rab25 is overexpressed in Müllerian serous carcinoma compared to malignant mesothelioma
   Virchows Arch (in press)
   PubMed 22249560

Publications 2012

1. Schee K, Flatmark K, Holm R, Boye K, Paus E (2012)
   Investigation of nonspecific cross-reacting antigen 2 as a prognostic biomarker in bone marrow plasma from colorectal cancer patients
   Tumour Biol, 33 (1), 73-83
   PubMed 22006279

Publications 2011

1. Berge G, Costea DE, Berg M, Rasmussen H, Grotterød I, Lothe RA, Mælandsmo GM, Flatmark K (2011)
   Coexpression and nuclear colocalization of metastasis-promoting protein S100A4 and p53 without mutual regulation in colorectal carcinoma
   Amino Acids, 41 (4), 875-84
   PubMed 20191297
2. Bratland A, Dueland S, Hollywood D, Flatmark K, Ree AH (2011)
   Gastrointestinal toxicity of vorinostat: reanalysis of phase 1 study results with emphasis on dose-volume effects of pelvic radiotherapy
   Radiat Oncol, 6, 33
   PubMed 21473790
3. Flatmark K, Borgen E, Nesland JM, Rasmussen H, Johannessen HO, Bukholm I, Rosales R, Hårklau L, Jacobsen HJ, Sandstad B, Boye K, Fodstad Ø (2011)
   Disseminated tumour cells as a prognostic biomarker in colorectal cancer
   Br J Cancer, 104 (9), 1434-9
   PubMed 21448171
4. Paus E, Haugen MH, Olsen KH, Flatmark K, Maelandsmo GM, Nilsson O, Röijer E, Lundin M, Fermér C, Samsonova M, Lebedin Y, Stigbrand T (2011)
   TD-11 workshop report: characterization of monoclonal antibodies to S100 proteins
   Tumour Biol, 32 (1), 1-12
   PubMed 20652782
5. Saelen MG, Flatmark K, Folkvord S, de Wijn R, Rasmussen H, Fodstad Ø, Ree AH (2011)
   Tumor kinase activity in locally advanced rectal cancer: angiogenic signaling and early systemic dissemination
   Angiogenesis, 14 (4), 481-9
   PubMed 21833622
6. Wiig JN, Larsen SG, Dueland S, Flatmark K, Giercksky KE (2011)
   Salvage surgery for locally recurrent rectal cancer: total mesorectal excision during the primary operation does not influence the outcome
   Colorectal Dis, 13 (5), 506-11
   PubMed 20236148

Publications 2010

1. Boye K, Nesland JM, Sandstad B, Mælandsmo GM, Flatmark K (2010)
   Nuclear S100A4 is a novel prognostic marker in colorectal cancer
   Eur J Cancer, 46 (16), 2919-25
   PubMed 20719498
2. Flatmark K, Davidson B, Kristian A, Stavnes HT, Førsund M, Reed W (2010)
   Exploring the peritoneal surface malignancy phenotype--a pilot immunohistochemical study of human pseudomyxoma peritonei and derived animal models
   Hum Pathol, 41 (8), 1109-19
   PubMed 20338618
3. Flatmark K, Ree AH (2010)
   Radiosensitizing drugs: lessons to be learned from the oxaliplatin story
   J Clin Oncol, 28 (29), e577-8; author reply e581-3
   PubMed 20733124
4. Folkvord S, Flatmark K, Dueland S, de Wijn R, Grøholt KK, Hole KH, Nesland JM, Ruijtenbeek R, Boender PJ, Johansen M, Giercksky KE, Ree AH (2010)
   Prediction of response to preoperative chemoradiotherapy in rectal cancer by multiplex kinase activity profiling
   Int J Radiat Oncol Biol Phys, 78 (2), 555-62
   PubMed 20675069
5. Ree AH, Dueland S, Folkvord S, Hole KH, Seierstad T, Johansen M, Abrahamsen TW, Flatmark K (2010)
   Vorinostat, a histone deacetylase inhibitor, combined with pelvic palliative radiotherapy for gastrointestinal carcinoma: the Pelvic Radiation and Vorinostat (PRAVO) phase 1 study
   Lancet Oncol, 11 (5), 459-64
   PubMed 20378407
6. Schee K, Fodstad Ø, Flatmark K (2010)
   MicroRNAs as biomarkers in colorectal cancer
   Am J Pathol, 177 (4), 1592-9
   PubMed 20829435
7. Sørensen O, Andersen A, Olsen H, Alexandr K, Ekstrøm PO, Giercksky KE, Flatmark K (2010)
   Validation and use of microdialysis for determination of pharmacokinetic properties of the chemotherapeutic agent mitomycin C - an experimental study
   BMC Cancer, 10, 469
   PubMed 20809961

Publications 2009

1. Folkvord S, Ree AH, Furre T, Halvorsen T, Flatmark K (2009)
   Radiosensitization by SAHA in experimental colorectal carcinoma models-in vivo effects and relevance of histone acetylation status
   Int J Radiat Oncol Biol Phys, 74 (2), 546-52
   PubMed 19427556
2. Maelandsmo GM, Flørenes VA, Nguyen MT, Flatmark K, Davidson B (2009)
   Different expression and clinical role of S100A4 in serous ovarian carcinoma at different anatomic sites
   Tumour Biol, 30 (1), 15-25
   PubMed 19194111
3. Seierstad T, Hole KH, Saelen E, Ree AH, Flatmark K, Malinen E (2009)
   MR-guided simultaneous integrated boost in preoperative radiotherapy of locally advanced rectal cancer following neoadjuvant chemotherapy
   Radiother Oncol, 93 (2), 279-84
   PubMed 19800704

Publications 2008

1. Brunsvig PF, Flatmark K, Aamdal S, Høifødt H, Le H, Jakobsen E, Sandstad B, Fodstad O (2008)
   Bone marrow micrometastases in advanced stage non-small cell lung carcinoma patients
   Lung Cancer, 61 (2), 170-6
   PubMed 18261824
2. Folkvord S, Flatmark K, Seierstad T, Røe K, Rasmussen H, Ree AH (2008)
   Inhibitory effects of oxaliplatin in experimental radiation treatment of colorectal carcinoma: does oxaliplatin improve 5-fluorouracil-dependent radiosensitivity?
   Radiother Oncol, 86 (3), 428-34
   PubMed 18006097
3. Haugen MH, Flatmark K, Mikalsen SO, Malandsmo GM (2008)
   The metastasis-associated protein S100A4 exists in several charged variants suggesting the presence of posttranslational modifications
   BMC Cancer, 8, 172
   PubMed 18554396
4. Ree AH, Folkvord S, Flatmark K (2008)
   HDAC2 deficiency and histone acetylation
   Nat Genet, 40 (7), 812-3; author reply 813
   PubMed 18583969
5. Seierstad T, Røe K, Sitter B, Halgunset J, Flatmark K, Ree AH, Olsen DR, Gribbestad IS, Bathen TF (2008)
   Principal component analysis for the comparison of metabolic profiles from human rectal cancer biopsies and colorectal xenografts using high-resolution magic angle spinning 1H magnetic resonance spectroscopy
   Mol Cancer, 7, 33
   PubMed 18439252

Publications 2007

1. Flatmark K, Reed W, Halvorsen T, Sørensen O, Wiig JN, Larsen SG, Fodstad Ø, Giercksky KE (2007)
   Pseudomyxoma peritonei--two novel orthotopic mouse models portray the PMCA-I histopathologic subtype
   BMC Cancer, 7, 116
   PubMed 17603904
2. Seierstad T, Folkvord S, Røe K, Flatmark K, Skretting A, Olsen DR (2007)
   Early changes in apparent diffusion coefficient predict the quantitative antitumoral activity of capecitabine, oxaliplatin, and irradiation in HT29 xenografts in athymic nude mice
   Neoplasia, 9 (5), 392-400
   PubMed 17534444

Publications 2006

1. Flatmark K, Nome RV, Folkvord S, Bratland A, Rasmussen H, Ellefsen MS, Fodstad Ø, Ree AH (2006)
   Radiosensitization of colorectal carcinoma cell lines by histone deacetylase inhibition
   Radiat Oncol, 1, 25
   PubMed 16887021
2. Ree AH, Stokke T, Bratland A, Patzke S, Nome RV, Folkvord S, Meza-Zepeda LA, Flatmark K, Fodstad O, Andersson Y (2006)
   DNA damage responses in cell cycle G2 phase and mitosis--tracking and targeting
   Anticancer Res, 26 (3A), 1909-16
   PubMed 16827124

Publications 2005

1. Bjørnland K, Flatmark K, Pettersen S, Aaasen AO, Fodstad O, Maelandsmo GM (2005)
   Matrix metalloproteinases participate in osteosarcoma invasion
   J Surg Res, 127 (2), 151-6
   PubMed 16083752

Publications 2004

1. Flatmark K, Maelandsmo GM, Martinsen M, Rasmussen H, Fodstad Ø (2004)
   Twelve colorectal cancer cell lines exhibit highly variable growth and metastatic capacities in an orthotopic model in nude mice
   Eur J Cancer, 40 (10), 1593-8
   PubMed 15196545
2. Flatmark K, Maelandsmo GM, Mikalsen SO, Nustad K, Varaas T, Rasmussen H, Meling GI, Fodstad Ø, Paus E (2004)
   Immunofluorometric assay for the metastasis-related protein S100A4: release of S100A4 from normal blood cells prohibits the use of S100A4 as a tumor marker in plasma and serum
   Tumour Biol, 25 (1-2), 31-40
   PubMed 15192310

Publications 2003

1. Bjørnland K, Flatmark K, Mala T, Mathisen O, Bakka A, Aasen AO, Bergan A, Søreide O, Fodstad O (2003)
   Detection of disseminated tumour cells in bone marrow of patients with isolated liver metastases from colorectal cancer
   J Surg Oncol, 82 (4), 224-7
   PubMed 12672004
2. Flatmark K, Pedersen KB, Nesland JM, Rasmussen H, Aamodt G, Mikalsen SO, Bjørnland K, Fodstad Ø, Maelandsmo GM (2003)
   Nuclear localization of the metastasis-related protein S100A4 correlates with tumour stage in colorectal cancer
   J Pathol, 200 (5), 589-95
   PubMed 12898594

Publications 2002

1. Flatmark K, Bjørnland K, Johannessen HO, Hegstad E, Rosales R, Hårklau L, Solhaug JH, Faye RS, Søreide O, Fodstad Ø, Study Group for Micrometastases in BM in Colorectal Cancer (2002)
   Immunomagnetic detection of micrometastatic cells in bone marrow of colorectal cancer patients
   Clin Cancer Res, 8 (2), 444-9
   PubMed 11839662

Publications 2000

1. Flatmark K, Nilsen BH (2000)
   [Postoperative wound infections in elective colorectal surgery]
   Tidsskr Nor Laegeforen, 120 (23), 2761-3
   PubMed 11107920